Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARDELYX, INC. Director's Dealing 2016

Nov 16, 2016

32003_dirs_2016-11-15_8f14ed3f-3b8d-4964-bb34-99507288793b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARDELYX, INC. (ARDX)
CIK: 0001437402
Period of Report: 2016-11-11

Reporting Person: Caldwell Jeremy S (EVP, Chief Scientific Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-11-11 Common Stock S 2158 $15.1277 Disposed 0 Direct

Footnotes

F1: Consists of 2,158 shares acquired under the Issuer's Employee Stock Purchase Plan on February 29, 2016 and August 31, 2016.